Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery

NCT05624424 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT05624424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05624424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Phase 4
Overall status
Unknown status
Start date
November 15, 2022
Completion date
October 31, 2023
Enrollment
1,317 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, general, emergence agitation, laparoscopic abdominal surgery, perioperative sedation, remimazolam besylate